Hearings / Energy and Commerce Committee

☆ Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Develop... Show more

House 119th · July 15, 2026 at 2:15 PM
Rayburn House Office Building, Room 2123 · Scheduled
Energy and Commerce Committee › Health Subcommittee · 30 members ↓
Griffith, H. Morgan R-VA Chair
Harshbarger, Diana R-TN Vice Chair
Carter, Earl L. "Buddy" R-GA
Rulli, Michael A. R-OH
Langworthy, Nicholas A. R-NY
Bentz, Cliff R-OR
Crenshaw, Dan R-TX
Houchin, Erin R-IN
Kean, Thomas H. R-NJ
Obernolte, Jay R-CA
James, John R-MI
Joyce, John R-PA
Cammack, Kat R-FL
Bilirakis, Gus M. R-FL
Miller-Meeks, Mariannette R-IA
Dunn, Neal P. R-FL
Balderson, Troy R-OH
DeGette, Diana D-CO Ranking
Carter, Troy A. D-LA
Veasey, Marc A. D-TX
Ocasio-Cortez, Alexandria D-NY
Dingell, Debbie D-MI
Barragán, Nanette Diaz D-CA
Landsman, Greg D-OH
Auchincloss, Jake D-MA
Schrier, Kim D-WA
Kelly, Robin L. D-IL
Fletcher, Lizzie D-TX
Trahan, Lori D-MA
Ruiz, Raul D-CA
Witnesses (5) Show all +
Dr. Cynthia Verst
President, Design and Delivery Innovation, R&D Solutions, IQVIA
Ms. Susan Winckler
CEO, Reagan-Udall Foundation for the FDA
Dr. Aaron Kowalski
CEO, Breakthrough T1D
Dr. Thomas Hwang
Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
Mr. Thomas Bollyky
Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council

Free access to AI-generated transcripts

Speaker identification, synchronized video playback, full-text search, and deep linking — all free.

Create Free Account
Browse hearings with transcripts